Direct vascular effects of HMG-CoA reductase inhibitors

This publication has 59 references indexed in Scilit:

• Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• HMG-CoA Reductase Inhibitors Reduce Acetyl LDL Endocytosis in Mouse Peritoneal Macrophages
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
• HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
• Effect of Lovastatin on Suppression and Regression of Atherosclerosis in Lipid-Fed Rabbits
  Journal of Cardiovascular Pharmacology, 1992
• Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in Humans
  The Journal of Clinical Pharmacology, 1992
• Regulation of the mevalonate pathway
  Nature, 1990
• CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986